Given the increased use of glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drugs over the past few years, there remains a need to establish whether this therapy is associated with age-related macular degeneration (AMD) risk, as has been proposed
The rebound effect is temporary, usually lasting a few days as natural adrenal function returns to baseline
Apply once per day and increase to twice a day if well tolerated
"These medications are transforming obesity care, but we know very little about how they shape people's daily lives, including changes in appetite, eating patterns, well-being, and quality of life," Dr
Diabetes Spectrum: A Publication of the American Diabetes Association, 30(3), 157160